Carlos Rodríguez‐Galindo

27.5k total citations · 4 hit papers
356 papers, 13.7k citations indexed

About

Carlos Rodríguez‐Galindo is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Carlos Rodríguez‐Galindo has authored 356 papers receiving a total of 13.7k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Oncology, 99 papers in Surgery and 89 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Carlos Rodríguez‐Galindo's work include Childhood Cancer Survivors' Quality of Life (71 papers), Sarcoma Diagnosis and Treatment (62 papers) and Neuroblastoma Research and Treatments (61 papers). Carlos Rodríguez‐Galindo is often cited by papers focused on Childhood Cancer Survivors' Quality of Life (71 papers), Sarcoma Diagnosis and Treatment (62 papers) and Neuroblastoma Research and Treatments (61 papers). Carlos Rodríguez‐Galindo collaborates with scholars based in United States, Canada and United Kingdom. Carlos Rodríguez‐Galindo's co-authors include Iyad Sultan, Matthew W. Wilson, Andrea Ferrari, Ibrahim Qaddoumi, Catherine A. Billups, Raul C. Ribeiro, A. Lindsay Frazier, Carl E. Allen, Michela Casanova and Alberto S. Pappo and has published in prestigious journals such as Nature, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Carlos Rodríguez‐Galindo

341 papers receiving 13.4k citations

Hit Papers

Langerhans cell histiocytosis (LCH): Guidelines for diagn... 2012 2026 2016 2021 2012 2018 2015 2019 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Langerhans cell histiocytosis (LCH): Guidelines for diagnosis, clinical work‐up, and treatment for patients till the age of 18 years
    2012 372 citations Carlos Rodríguez‐Galindo et al. Pediatric Blood & Cancer profile →
  2. Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease
    2018 313 citations Carlos Rodríguez‐Galindo, Carl E. Allen et al. Blood profile →
  3. Toward the Cure of All Children With Cancer Through Collaborative Efforts: Pediatric Oncology As a Global Challenge
    2015 280 citations Carlos Rodríguez‐Galindo, Sima Jeha et al. Journal of Clinical Oncology profile →
  4. Childhood cancer burden: a review of global estimates
    2019 246 citations Nickhill Bhakta, A. Lindsay Frazier et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Carlos Rodríguez‐Galindo United States 63 4.1k 3.7k 3.5k 2.6k 2.0k 356 13.7k
Gemma Gatta Italy 59 5.3k 1.3× 2.6k 0.7× 2.9k 0.8× 2.0k 0.8× 1.2k 0.6× 205 11.9k
Marilyn Stovall United States 74 3.7k 0.9× 3.5k 0.9× 2.0k 0.6× 2.0k 0.8× 5.8k 2.9× 166 16.9k
Mark Krailo United States 76 5.7k 1.4× 6.8k 1.8× 4.1k 1.2× 4.5k 1.7× 1.9k 0.9× 392 18.7k
Charles Stiller United Kingdom 63 3.4k 0.8× 2.9k 0.8× 1.5k 0.4× 2.6k 1.0× 5.5k 2.8× 223 13.9k
Frederick P. Li United States 50 5.7k 1.4× 2.7k 0.7× 1.2k 0.3× 5.8k 2.2× 1.5k 0.7× 131 13.8k
Sarah S. Donaldson United States 80 5.0k 1.2× 9.5k 2.5× 4.0k 1.1× 2.5k 1.0× 6.4k 3.2× 350 23.3k
Anna T. Meadows United States 82 4.2k 1.0× 4.0k 1.1× 2.1k 0.6× 2.7k 1.0× 10.4k 5.3× 229 22.0k
Michelle Petri United States 99 2.2k 0.6× 1.4k 0.4× 1.8k 0.5× 2.6k 1.0× 354 0.2× 534 33.5k
Munther A. Khamashta United Kingdom 84 1.7k 0.4× 2.5k 0.7× 3.1k 0.9× 1.8k 0.7× 291 0.1× 411 31.3k
Charles B. Pratt United States 50 2.8k 0.7× 3.7k 1.0× 1.7k 0.5× 1.5k 0.6× 1.0k 0.5× 198 8.5k

Countries citing papers authored by Carlos Rodríguez‐Galindo

Since Specialization
Citations

This map shows the geographic impact of Carlos Rodríguez‐Galindo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carlos Rodríguez‐Galindo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carlos Rodríguez‐Galindo more than expected).

Fields of papers citing papers by Carlos Rodríguez‐Galindo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carlos Rodríguez‐Galindo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carlos Rodríguez‐Galindo. The network helps show where Carlos Rodríguez‐Galindo may publish in the future.

Co-authorship network of co-authors of Carlos Rodríguez‐Galindo

This figure shows the co-authorship network connecting the top 25 collaborators of Carlos Rodríguez‐Galindo. A scholar is included among the top collaborators of Carlos Rodríguez‐Galindo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carlos Rodríguez‐Galindo. Carlos Rodríguez‐Galindo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
O’Neill, Allison F., Raul C. Ribeiro, Emília M. Pinto, et al.. (2024). Pediatric Adrenocortical Carcinoma: The Nuts and Bolts of Diagnosis and Treatment and Avenues for Future Discovery. Cancer Management and Research. Volume 16. 1141–1153. 2 indexed citations
2.
Berg, F.D. van den, et al.. (2024). The transformation of Cure4Kids: Expanding knowledge transfer capacity. Pediatric Blood & Cancer. 71(8). e31135–e31135. 3 indexed citations
3.
O’Neill, Allison F., Alanna J. Church, Heung Bae Kim, et al.. (2024). Clinical and immunophenotype correlating with response to immunotherapy in paediatric patients with primary liver carcinoma. A case series. EBioMedicine. 104. 105147–105147. 1 indexed citations
4.
Graetz, Dylan E., Inam Chitsike, Nickhill Bhakta, et al.. (2024). Stigma in Pediatric Cancer: An Exploratory Study of Osteosarcoma and Retinoblastoma in Guatemala, Jordan, and Zimbabwe. JCO Global Oncology. 10(10). e2400017–e2400017. 2 indexed citations
5.
Ward, Richard, Hannah M. Jones, Frederick A. Boop, et al.. (2022). Outcomes of Children With Low-Grade Gliomas in Low- and Middle-Income Countries: A Systematic Review. JCO Global Oncology. 8(8). e2200199–e2200199. 12 indexed citations
6.
Rodríguez‐Galindo, Carlos & Carl E. Allen. (2020). Langerhans cell histiocytosis. Blood. 135(16). 1319–1331. 168 indexed citations
7.
Fonseca, Adriana, Caihong Xia, Armando J. Lorenzo, et al.. (2018). Detection of Relapse by Tumor Markers Versus Imaging in Children and Adolescents With Nongerminomatous Malignant Germ Cell Tumors: A Report From the Children’s Oncology Group. Journal of Clinical Oncology. 37(5). 396–402. 9 indexed citations
8.
Pinto, Emília M., Carlos Rodríguez‐Galindo, John Choi, et al.. (2016). Prognostic Significance of Major Histocompatibility Complex Class II Expression in Pediatric Adrenocortical Tumors: A St. Jude and Children's Oncology Group Study. Clinical Cancer Research. 22(24). 6247–6255. 24 indexed citations
9.
Merchant, Melinda S., Matthew Wright, Kristin Baird, et al.. (2015). Phase I Clinical Trial of Ipilimumab in Pediatric Patients with Advanced Solid Tumors. Clinical Cancer Research. 22(6). 1364–1370. 234 indexed citations
10.
Ban, Jozef, Dave N.T. Aryee, Wietske van der Ent, et al.. (2014). Suppression of Deacetylase SIRT1 Mediates Tumor-Suppressive NOTCH Response and Offers a Novel Treatment Option in Metastatic Ewing Sarcoma. Cancer Research. 74(22). 6578–6588. 57 indexed citations
11.
Ladra, Matthew, Jackie Szymonifka, Anita Mahajan, et al.. (2014). Preliminary Results of a Phase II Trial of Proton Radiotherapy for Pediatric Rhabdomyosarcoma. Journal of Clinical Oncology. 32(33). 3762–3770. 91 indexed citations
12.
Pinto, Emília M., Christopher L. Morton, Carlos Rodríguez‐Galindo, et al.. (2013). Establishment and Characterization of the First Pediatric Adrenocortical Carcinoma Xenograft Model Identifies Topotecan as a Potential Chemotherapeutic Agent. Clinical Cancer Research. 19(7). 1740–1747. 27 indexed citations
13.
Wong, Jeannette R., Jenine K. Harris, Carlos Rodríguez‐Galindo, & Kimberly Johnson. (2013). Incidence of Childhood and Adolescent Melanoma in the United States: 1973–2009. PEDIATRICS. 131(5). 846–854. 121 indexed citations
14.
Bauer, Daniel E., Chelsey M. Mitchell, Kelly M. Strait, et al.. (2012). Clinicopathologic Features and Long-term Outcomes of NUT Midline Carcinoma. Clinical Cancer Research. 18(20). 5773–5779. 276 indexed citations
15.
Wilson, Matthew W., et al.. (2009). Expression of the Multi-Drug Resistance Proteins and the Pregnane X Receptor in Treated and Untreated Retinoblastoma. Current Eye Research. 34(5). 386–394. 9 indexed citations
16.
Furman, Wayne L., Fariba Navid, Najat C. Daw, et al.. (2009). Tyrosine Kinase Inhibitor Enhances the Bioavailability of Oral Irinotecan in Pediatric Patients With Refractory Solid Tumors. Journal of Clinical Oncology. 27(27). 4599–4604. 42 indexed citations
17.
Saab, Raya, Carlos Rodríguez‐Galindo, Jerold E. Rehg, et al.. (2009). p18Ink4c and p53 Act as Tumor Suppressors in Cyclin D1 –Driven Primitive Neuroectodermal Tumor. Cancer Research. 69(2). 440–448. 17 indexed citations
18.
West, Alina Nico, Geoffrey Neale, Stanley Pounds, et al.. (2007). Gene Expression Profiling of Childhood Adrenocortical Tumors. Cancer Research. 67(2). 600–608. 116 indexed citations
19.
Johnson, Dianna A., Jiakun Zhang, Sharon Frase, et al.. (2007). Neuronal Differentiation and Synaptogenesis in Retinoblastoma. Cancer Research. 67(6). 2701–2711. 32 indexed citations
20.
Wilson, Matthew W., Charles H. Fraga, Christine Fuller, et al.. (2006). Immunohistochemical Detection of Multidrug-Resistant Protein Expression in Retinoblastoma Treated by Primary Enucleation. Investigative Ophthalmology & Visual Science. 47(4). 1269–1269. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gemma Gatta Breakdown of academic impact, for papers by Marilyn Stovall Breakdown of academic impact, for papers by Mark Krailo Breakdown of academic impact, for papers by Charles Stiller Breakdown of academic impact, for papers by Frederick P. Li Breakdown of academic impact, for papers by Sarah S. Donaldson Breakdown of academic impact, for papers by Anna T. Meadows Breakdown of academic impact, for papers by Michelle Petri Breakdown of academic impact, for papers by Munther A. Khamashta Breakdown of academic impact, for papers by Charles B. Pratt
Rankless by CCL
2026